Skip to main content
. 2024 Dec 11;9(51):50695–50704. doi: 10.1021/acsomega.4c08627

Table 3. Protective and Curative Effects of A9 against Aac In Vivoa.

    protective effect
 curative effect
sample concentration (μg/mL) disease index efficacy (%) disease index efficacy (%)
A9 200 10.56 ± 1.11c 61.5b 15.56 ± 0.96d 54.86b
100 15.37 ± 0.85b 43.9d 22.96 ± 0.64b 33.32d
thiodiazole copper 100 13.15 ± 0.32c 51.89c 17.59 ± 0.85c 48.94c
kasugamycin 100 8.89 ± 0.56d 67.57a 13.52 ± 0.32e 60.71a
CK   27.41 ± 1.70a   34.44 ± 1.11a  
a

Columns represent the mean ± SE. Different letters in the column represent significant difference at the P0.05 level, the same as following.